Pms83 - Comparison of French and German Hta Assessments for Three Recently Evaluated Rheumatoid Arthritis Drugs

Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.1797
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Pms84 - Comparison of Hta Assessments of Sarilumab in Different Subpopulations for Rheumatoid Arthritis

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

A Comparison of Clinical Assessments of Disease Activity in Rheumatoid Arthritis.

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
1980English

Anti-Inflammatory Drugs for Rheumatoid Arthritis

BMJ
1976English

Pcn321 - Comparison of Recommendations for Cancer Drugs Carried Out by Three Hta Bodies (2015-2018): Nice Technology Appraisals, German Federal Joint Committee and Spanish Therapeutic Positioning Report

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

The New 2012 German Recommendations for Treating Rheumatoid Arthritis

Zeitschrift fur Rheumatologie
Rheumatology
2013English

Predictors of Stopping and Starting Disease-Modifying Antirheumatic Drugs for Rheumatoid Arthritis

Arthritis Care and Research
Rheumatology
2014English

Virtual Screening of Natural Metabolites as Candidate Drugs for Rheumatoid Arthritis

International Journal of Recent Technology and Engineering
EngineeringManagement of TechnologyInnovation
2020English

Imaging for Diagnosis and Management of Rheumatoid Arthritis: Review of Three Cases

Orthopedics & Traumatology
2010English

Php287 - German Early Benefit Assessments of Orphan Drugs Under Full Dossier Conditions

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy